Relay Therapeutics, Inc. RLAY Return on invested capital

Return on invested capital at other companies

SchrodingerSDGR

-83.1%+94.1pp

Recursion Pharmaceuticals, Inc.RXRX

-116.4%-30.6pp

CelcuityCELC

-168.1%-1,894pp

Revolution Medicines, Inc.RVMD

-91.9%+112pp

Ligand PharmaceuticalsLGND

8.5%+6.3pp

ImmunomeIMNM

-746.6%+212pp

FAQ

What is Relay Therapeutics, Inc.'s return on invested capital?

Relay Therapeutics, Inc. (RLAY) reported return on invested capital of -44.8% in Q2 2026.

How has Relay Therapeutics, Inc.'s return on invested capital changed year-over-year?

Relay Therapeutics, Inc.'s return on invested capital increased by 22.6% year-over-year, from -57.9% to -44.8%.

What is the long-term trend for Relay Therapeutics, Inc.'s return on invested capital?

Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s return on invested capital has grown at a -9.6% compound annual growth rate (CAGR), from -74.4% to -49.7%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.